{"id":88814,"date":"2023-01-19T00:08:00","date_gmt":"2023-01-18T17:08:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2023011900080088814"},"modified":"2023-01-19T22:20:41","modified_gmt":"2023-01-19T14:20:41","slug":"%e5%92%8c%e9%bb%84%e5%8c%bb%e8%8d%af%e5%ae%a3%e5%b8%83%e4%b8%8e%e5%9b%bd%e5%ae%b6%e5%8c%bb%e4%bf%9d%e5%b1%80%e8%be%be%e6%88%90%e5%8d%8f%e8%ae%ae%e6%b2%83%e7%91%9e%e6%b2%99r%e8%8e%b7%e7%ba%b3","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2023011900080088814","title":{"rendered":"\u548c\u9ec4\u533b\u836f\u5ba3\u5e03\u4e0e\u56fd\u5bb6\u533b\u4fdd\u5c40\u8fbe\u6210\u534f\u8bae\u6c83\u745e\u6c99(R)\u83b7\u7eb3\u5165\u4e2d\u56fd\u56fd\u5bb6\u533b\u4fdd\u836f\u54c1\u76ee\u5f55"},"content":{"rendered":"<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/www.xinwengao.com\/cn\/wp-content\/uploads\/HUTCHMED_Logo_Logo-5.jpg\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><p><span class=\"legendSpanClass\">\u9999\u6e2f\u3001\u4e0a\u6d77\u548c\u65b0\u6cfd\u897f\u5dde<\/span><span class=\"legendSpanClass\">2023\u5e741\u670819\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212; \u548c\u9ec4\u533b\u836f\uff08\u4e2d\u56fd\uff09\u6709\u9650\u516c\u53f8\uff08\u7b80\u79f0&quot;<a href=\"https:\/\/www.hutch-med.com\/sc\/home\/\" target=\"_blank\" rel=\"nofollow noopener\">\u548c\u9ec4\u533b\u836f<\/a>&quot;\u6216&quot;HUTCHMED&quot;\uff09\uff08\u7eb3\u65af\u8fbe\u514b\/\u4f26\u6566\u8bc1\u4ea4\u6240\uff1aHCM\uff1b\u9999\u6e2f\u4ea4\u6613\u6240\uff1a13\uff09\u4eca\u5929\u5ba3\u5e03\uff0c\u7ecf\u8fc7\u4e0e\u4e2d\u56fd\u56fd\u5bb6\u533b\u7597\u4fdd\u969c\u5c40\uff08&quot;\u56fd\u5bb6\u533b\u4fdd\u5c40&quot;\uff09\u7684\u533b\u4fdd\u8c08\u5224\uff0c\u6c83\u745e\u6c99&reg;\uff08\u8d5b\u6c83\u66ff\u5c3c\uff09\u83b7\u7eb3\u5165\u65b0\u7248\u300a\u56fd\u5bb6\u57fa\u672c\u533b\u7597\u4fdd\u9669\u3001\u5de5\u4f24\u4fdd\u9669\u548c\u751f\u80b2\u4fdd\u9669\u836f\u54c1\u76ee\u5f55\u300b\uff08&quot;\u533b\u4fdd\u836f\u54c1\u76ee\u5f55&quot;\uff09\uff0c\u7528\u4e8e\u6cbb\u7597\u542b\u94c2\u5316\u7597\u540e\u75be\u75c5\u8fdb\u5c55\u6216\u4e0d\u8010\u53d7\u6807\u51c6\u542b\u94c2\u5316\u7597\u7684\u95f4\u5145\u8d28\u4e0a\u76ae\u8f6c\u5316\u56e0\u5b50\uff08&quot;MET&quot;\uff09 \u5916\u663e\u5b50&nbsp;14 \u8df3\u53d8\u7684\u5c40\u90e8\u665a\u671f\u6216\u8f6c\u79fb\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u6210\u4eba\u60a3\u8005\u3002\u65b0\u7248\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\u5c06\u81ea2023\u5e743\u67081\u65e5\u8d77\u751f\u6548\u3002<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<\/p><\/div>\n<p>\u8d5b\u6c83\u66ff\u5c3c\u5728\u4e2d\u56fd\u4ee5\u5546\u54c1\u540d\u6c83\u745e\u6c99&reg;\u4e0a\u5e02\uff0c\u662f\u4e00\u79cd\u5f3a\u6548\u3001\u9ad8\u9009\u62e9\u6027\u7684\u53e3\u670dMET\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff08&quot;TKI&quot;\uff09\uff0c\u7531\u963f\u65af\u5229\u5eb7\u4e0e\u548c\u9ec4\u533b\u836f\u8054\u5408\u5f00\u53d1\uff0c\u5176\u4e2d\u5728\u4e2d\u56fd\u7684\u8054\u5408\u5f00\u53d1\u7531\u548c\u9ec4\u533b\u836f\u4e3b\u5bfc\uff0c\u5e76\u7531\u963f\u65af\u5229\u5eb7\u8d1f\u8d23\u5728\u5168\u7403\u8303\u56f4\u5185\u7684\u5546\u4e1a\u5316\u3002<\/p>\n<p>\u548c\u9ec4\u533b\u836f\u9996\u5e2d\u6267\u884c\u5b98\u517c\u9996\u5e2d\u79d1\u5b66\u5b98\u82cf\u6170\u56fd\u535a\u58eb\u8868\u793a\uff1a&quot;\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\u80fd\u591f\u5e2e\u52a9\u66f4\u5e7f\u6cdb\u7684\u4e2d\u56fd\u60a3\u8005\u7528\u4e0a\u521b\u65b0\u836f\u3002\u5f88\u9ad8\u5174\u770b\u5230\u6211\u4eec\u7b2c\u4e09\u6b3e\u521b\u65b0\u6297\u80bf\u7624\u836f\u7269\u6c83\u745e\u6c99&reg;\u83b7\u7eb3\u5165\u4eca\u5e74\u7684\u65b0\u7248\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\u3002 \u4f5c\u4e3a\u4e2d\u56fd\u5e02\u573a\u4e0a\u9996\u4e2a\u4ea6\u662f\u76ee\u524d\u552f\u4e00\u83b7\u6279\u4e0a\u5e02\u7684\u9009\u62e9\u6027MET\u6291\u5236\u5242\uff0c\u6c83\u745e\u6c99&reg;\u83b7\u7eb3\u5165\u533b\u4fdd\uff0c\u5c06\u5927\u5927\u63d0\u9ad8\u8be5\u521b\u65b0\u7597\u6cd5\u7684\u53ef\u8d1f\u62c5\u6027\u548c\u53ef\u53ca\u6027\u3002&quot;<\/p>\n<p>\u963f\u65af\u5229\u5eb7\u5168\u7403\u6267\u884c\u526f\u603b\u88c1\u3001\u56fd\u9645\u4e1a\u52a1\u53ca\u4e2d\u56fd\u603b\u88c1\u738b\u78ca\u5148\u751f\u8868\u793a\uff1a&quot;\u6b64\u6b21\u6c83\u745e\u6c99&reg;\u83b7\u7eb3\u5165\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\uff0c\u5bf9\u4e8e\u6570\u4ee5\u5343\u8ba1\u7684MET\u5916\u663e\u5b5014\u8df3\u8dc3\u7a81\u53d8\u7684\u4e2d\u56fd\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u6765\u8bf4\uff0c\u662f\u4e00\u4e2a\u4ee4\u4eba\u632f\u594b\u7684\u6d88\u606f\u3002\u8fd9\u4e9b\u60a3\u8005\u5f80\u5f80\u5bf9\u5316\u7597\u53cd\u5e94\u4e0d\u4f73\uff0c\u73b0\u5728\u4ed6\u4eec\u80fd\u591f\u66f4\u5bb9\u6613\u5730\u83b7\u53d6\u8be5\u9002\u5e94\u75c7\u552f\u4e00\u83b7\u6279\u7684\u9776\u5411\u836f\u7269\u3002\u6c83\u745e\u6c99&reg;\u81ea2021\u5e74\u5e74\u4e2d\u4e0a\u5e02\u4ee5\u6765\uff0c\u5df2\u5e2e\u52a9\u6709\u9700\u8981\u7684\u60a3\u8005\u83b7\u5f97\u66f4\u597d\u7684\u6cbb\u7597\u6548\u679c\uff0c\u6211\u4eec\u5f88\u671f\u5f85\u66f4\u591a\u4e2d\u56fd\u60a3\u8005\u5c06\u6709\u671b\u83b7\u76ca\u4e8e\u8be5\u9769\u547d\u6027\u7684\u836f\u7269\u3002&quot;<\/p>\n<p>\u6c83\u745e\u6c99&reg;\u4e8e2021\u5e746\u6708\u5728\u4e2d\u56fd\u83b7\u9644\u6761\u4ef6\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u7279\u5b9a\u7684MET\u5916\u663e\u5b5014\u8df3\u8dc3\u7a81\u53d8\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u3002<\/p>\n<p><b>\u5173\u4e8e\u533b\u4fdd\u836f\u54c1\u76ee\u5f55<\/b><\/p>\n<p>\u8fd1\u5e74\u6765\uff0c\u4e2d\u56fd\u653f\u5e9c\u9ad8\u5ea6\u91cd\u89c6\u51cf\u8f7b\u4eba\u6c11\u7fa4\u4f17\u7528\u836f\u8d1f\u62c5\u95ee\u9898\u3002\u56fd\u5bb6\u533b\u4fdd\u5c40\u76ee\u524d\u5b9a\u671f\u53ec\u96c6\u4e00\u4e2a\u5e7f\u6cdb\u7684\u4e13\u5bb6\u7f51\u7edc\uff0c\u5305\u62ec\u533b\u5b66\u4e13\u5bb6\u3001\u836f\u5b66\u4e13\u5bb6\u548c\u836f\u7269\u7ecf\u6d4e\u5b66\u4e13\u5bb6\u7b49\uff0c\u5bf9\u521b\u65b0\u836f\u7269\u51c6\u5165\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\u8fdb\u884c\u66f4\u65b0\u548c\u8c03\u6574\u3002\u56e0\u6b64\u4e59\u7c7b\u836f\u7269\u7684\u62a5\u9500\u8303\u56f4\u8fc5\u901f\u6269\u5927\uff0c\u5176\u4e2d\u8d8a\u6765\u8d8a\u591a\u5730\u5305\u62ec\u65b0\u578b\u6297\u80bf\u7624\u836f\u7269\u3002\u4e59\u7c7b\u836f\u7269\u7684\u62a5\u9500\u8981\u6c42\u60a3\u8005\u6839\u636e\u5176\u5c45\u4f4f\u7701\u4efd\u6216\u53c2\u52a0\u7684\u533b\u7597\u4fdd\u9669\u7c7b\u578b\uff0c\u652f\u4ed8\u4e0d\u540c\u6bd4\u4f8b\u7684\u81ea\u4ed8\u989d\u3002\u6240\u6709\u5305\u62ec\u7684\u836f\u7269\u7684\u534f\u8bae\u901a\u5e38\u6bcf\u4e24\u5e74\u66f4\u65b0\u4e00\u6b21\u3002<\/p>\n<p>\u5728\u8fd9\u6b21\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\u8c03\u6574\u4e2d\uff0c\u56fd\u5bb6\u533b\u4fdd\u5c40\u5171\u65b0\u589e23\u4e2a\u6297\u80bf\u7624\u836f\u7269\uff0c\u5176\u4e2d\u5305\u62ec\u6c83\u745e\u6c99&reg;\u3002\u81ea2023\u5e743\u67081\u65e5\u8d77\uff0c\u5c06\u5728\u5168\u56fd\u5404\u5927\u533b\u9662\u836f\u623f\u6309\u7167\u533b\u4fdd\u652f\u4ed8\u6807\u51c6\u6267\u884c\u8c08\u5224\u4ef7\u683c\uff0c\u5e76\u5bf9\u53c2\u4fdd\u4eba\u5458\u6309\u7167\u4e00\u5b9a\u6bd4\u4f8b\u7ed9\u4ed8\u3002<\/p>\n<p><b>\u5173\u4e8e\u8d5b\u6c83\u66ff\u5c3c<\/b><\/p>\n<p>\u8d5b\u6c83\u66ff\u5c3c\u662f\u4e00\u79cd\u5f3a\u6548\u3001\u9ad8\u9009\u62e9\u6027\u7684\u53e3\u670dMET TKI\uff0c\u5728\u665a\u671f\u5b9e\u4f53\u7624\u4e2d\u8868\u73b0\u51fa\u4e34\u5e8a\u6d3b\u6027\u3002\u8d5b\u6c83\u66ff\u5c3c\u53ef\u963b\u65ad\u56e0\u7a81\u53d8\uff08\u4f8b\u5982\u5916\u663e\u5b5014\u8df3\u8dc3\u7a81\u53d8\u6216\u5176\u4ed6\u70b9\u7a81\u53d8\uff09\u3001\u57fa\u56e0\u6269\u589e\u6216\u86cb\u767d\u8d28\u8fc7\u8868\u8fbe\u800c\u5bfc\u81f4\u7684MET\u53d7\u4f53\u916a\u6c28\u9178\u6fc0\u9176\u4fe1\u53f7\u901a\u8def\u7684\u5f02\u5e38\u6fc0\u6d3b\u3002<\/p>\n<p>\u8d5b\u6c83\u66ff\u5c3c\u5728\u4e2d\u56fd\u4ee5\u5546\u54c1\u540d\u6c83\u745e\u6c99&reg;<a href=\"https:\/\/www.hutch-med.com\/sc\/first-commercial-sale-of-orpathys-milestone-payment\/\" target=\"_blank\" rel=\"nofollow noopener\">\u4e0a\u5e02<\/a>\uff0c\u7528\u4e8e\u6cbb\u7597\u63a5\u53d7\u5168\u8eab\u6027\u6cbb\u7597\u540e\u75be\u75c5\u8fdb\u5c55\u6216\u65e0\u6cd5\u63a5\u53d7\u5316\u7597\u7684MET\u5916\u663e\u5b5014\u8df3\u8dc3\u7a81\u53d8\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u3002\u76ee\u524d\uff0c\u8d5b\u6c83\u66ff\u5c3c\u6b63\u4f5c\u4e3a\u5355\u836f\u7597\u6cd5\u6216\u4e0e\u5176\u4ed6\u836f\u7269\u7684\u8054\u5408\u7597\u6cd5\uff0c\u5f00\u53d1\u7528\u4e8e\u6cbb\u7597\u5305\u62ec\u80ba\u764c\u3001\u80be\u764c\u548c\u80c3\u764c\u5728\u5185\u7684\u591a\u79cd\u80bf\u7624\u7c7b\u578b\u3002<\/p>\n<p><b>\u5173\u4e8e\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u53caMET\u5f02\u5e38<\/b><\/p>\n<p>\u80ba\u764c\u662f\u7537\u6027\u548c\u5973\u6027\u764c\u75c7\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\uff0c\u7ea6\u5360\u6240\u6709\u764c\u75c7\u6b7b\u4ea1\u4eba\u6570\u7684\u4e94\u5206\u4e4b\u4e00\u3002<sup>1<\/sup>&nbsp;\u80ba\u764c\u901a\u5e38\u5206\u4e3a\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u548c\u5c0f\u7ec6\u80de\u80ba\u764c\uff08SCLC\uff09\uff0c\u5176\u4e2d80-85%\u4e3a\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u3002<sup>2<\/sup>&nbsp;\u5927\u90e8\u5206\uff08\u7ea675%\uff09\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u5728\u786e\u8bca\u65f6\u5df2\u662f\u665a\u671f\uff0c\u800c\u7f8e\u56fd\u548c\u6b27\u6d32\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u4e2d\u7ea6\u670910-25\uff05\u5b58\u5728EGFR\u7a81\u53d8\uff0c\u800c\u4e9a\u6d32\u60a3\u8005\u4e2d\u8be5\u6bd4\u4f8b\u9ad8\u8fbe30-40\uff05\u3002<sup>3, 4,&nbsp; 5, 6<\/sup><\/p>\n<p>MET\u662f\u4e00\u79cd\u53d7\u4f53\u916a\u6c28\u9178\u6fc0\u9176\uff0c\u5728\u7ec6\u80de\u7684\u6b63\u5e38\u53d1\u80b2\u8fc7\u7a0b\u4e2d\u53d1\u6325\u91cd\u8981\u4f5c\u7528\u3002<sup>7<\/sup>&nbsp;MET\u6269\u589e\u6216\u8fc7\u8868\u8fbe\u53ef\u5bfc\u81f4\u80bf\u7624\u751f\u957f\u4ee5\u53ca\u764c\u7ec6\u80de\u7684\u8f6c\u79fb\u8fdb\u5c55\uff0c\u4e14\u662fEGFR\u7a81\u53d8\u7684\u8f6c\u79fb\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u5bf9EGFR TKI\u6cbb\u7597\u4ea7\u751f\u83b7\u5f97\u6027\u8010\u836f\u7684\u4e3b\u8981\u673a\u5236\u4e4b\u4e00\u3002<sup>7,<\/sup><sup>&nbsp;8<\/sup>&nbsp;&nbsp;\u7ea6\u67092%-3%\u7684\u60a3\u8005\u4f34\u6709MET\u5916\u663e\u5b5014\u8df3\u8dc3\u7a81\u53d8\uff0c\u8fd9\u662f\u4e00\u79cd\u7279\u5b9a\u7684\u57fa\u56e0\u7a81\u53d8\u3002<sup>9 <\/sup>\u5728\u5965\u5e0c\u66ff\u5c3c\u6cbb\u7597\u540e\u51fa\u73b0\u75be\u75c5\u8fdb\u5c55\u7684\u60a3\u8005\u4e2d\uff0cMET\u5f02\u5e38\u7684\u53d1\u751f\u7387\u4e3a15-50%\u3002<sup>10,11,12,13,14<\/sup>&nbsp; MET\u6269\u589e\u548c\u8fc7\u8868\u8fbe\u7684\u53d1\u751f\u7387\u53ef\u80fd\u56e0\u6837\u54c1\u7c7b\u578b\u3001\u68c0\u6d4b\u65b9\u6cd5\u548c\u4f7f\u7528\u7684\u6d4b\u5b9a\u9608\u503c\u800c\u5f02\u3002<sup>15<\/sup><\/p>\n<p><b>\u5173\u4e8e\u963f\u65af\u5229\u5eb7\u4e0e\u548c\u9ec4\u533b\u836f\u7684\u5408\u4f5c<\/b><\/p>\n<p>\u548c\u9ec4\u533b\u836f\u4e0e\u963f\u65af\u5229\u5eb7\u4e8e2011\u5e74\u8fbe\u6210\u4e00\u9879\u5168\u7403\u8bb8\u53ef\u548c\u5408\u4f5c\u534f\u8bae\uff0c\u65e8\u5728\u5171\u540c\u5f00\u53d1\u8d5b\u6c83\u66ff\u5c3c\u5e76\u4fc3\u8fdb\u5176\u5546\u4e1a\u5316\u3002\u8d5b\u6c83\u66ff\u5c3c\u5728\u4e2d\u56fd\u7684\u8054\u5408\u5f00\u53d1\u7531\u548c\u9ec4\u533b\u836f\u4e3b\u5bfc\uff0c\u5e76\u7531\u963f\u65af\u5229\u5eb7\u4e3b\u5bfc\u5176\u6d77\u5916\u5f00\u53d1\u3002\u548c\u9ec4\u533b\u836f\u8d1f\u8d23\u8d5b\u6c83\u66ff\u5c3c\u5728\u4e2d\u56fd\u7684\u4e0a\u5e02\u8bb8\u53ef\u3001\u751f\u4ea7\u548c\u4f9b\u5e94\uff0c\u800c\u963f\u65af\u5229\u5eb7\u5219\u8d1f\u8d23\u8d5b\u6c83\u66ff\u5c3c\u5728\u4e2d\u56fd\u4e43\u81f3\u5168\u7403\u8303\u56f4\u5185\u7684\u5546\u4e1a\u5316\u3002\u8d5b\u6c83\u66ff\u5c3c\u7684\u9500\u552e\u6536\u5165\u7531\u963f\u65af\u5229\u5eb7\u786e\u8ba4\u3002<\/p>\n<p><b>\u5173\u4e8e\u963f\u65af\u5229\u5eb7\u5728\u80ba\u764c\u9886\u57df\u7684\u7814\u7a76<\/b><\/p>\n<p>\u963f\u65af\u5229\u5eb7\u6b63\u81f4\u529b\u4e8e\u901a\u8fc7\u65e9\u8bca\u65e9\u6cbb\u63d0\u9ad8\u80ba\u764c\u60a3\u8005\u7684\u6cbb\u6108\u7387\uff0c\u540c\u65f6\u63a8\u52a8\u76f8\u5173\u6280\u672f\u4e0d\u65ad\u5411\u524d\u53d1\u5c55\uff0c\u4ee5\u6539\u5584\u4ea7\u751f\u8010\u836f\u6027\u548c\u5904\u4e8e\u665a\u671f\u60c5\u51b5\u4e0b\u7684\u60a3\u8005\u7684\u6cbb\u7597\u7ed3\u679c\u3002\u901a\u8fc7\u5236\u5b9a\u65b0\u7684\u6cbb\u7597\u76ee\u6807\u548c\u7814\u7a76\u521b\u65b0\u7597\u6cd5\uff0c\u963f\u65af\u5229\u5eb7\u81f4\u529b\u4e8e\u5b9e\u73b0\u7528\u836f\u60a3\u8005\u53d7\u76ca\u6700\u5927\u5316\u7684\u76ee\u6807\u3002<\/p>\n<p>\u516c\u53f8\u4e30\u5bcc\u7684\u4ea7\u54c1\u7ec4\u5408\u5305\u62ec\u9886\u5148\u7684\u80ba\u764c\u836f\u7269\u4ee5\u53ca\u4e0b\u4e00\u9636\u6bb5\u7684\u521b\u65b0\u836f\u7269\uff0c\u5305\u62ec\u6cf0\u745e\u6c99&reg;\uff08\u5965\u5e0c\u66ff\u5c3c\uff09\u3001\u6613\u745e\u6c99&reg;\uff08\u5409\u975e\u66ff\u5c3c\u7247\uff09\u3001\u82f1\u98de\u51e1&reg;\uff08&nbsp;\u5ea6\u4f10\u5229\u5c24\u5355\u6297\uff09\u548cIMJUDO<sup>&reg;<\/sup>\uff08\u66f2\u7f8e\u6728\u5355\u6297\uff09\uff1b\u4e0e\u7b2c\u4e00\u4e09\u5171\uff08Daiichi Sankyo\uff09\u5408\u4f5c\u7814\u53d1\u7684ENHERTU&reg; (trastuzumab deruxtecan) \u548cdatopotamab deruxtecan\uff1b\u4e0e\u548c\u9ec4\u533b\u836f\u5408\u4f5c\u7814\u53d1\u7684\u6c83\u745e\u6c99&reg;\uff08\u8d5b\u6c83\u66ff\u5c3c\uff09\uff1b\u540c\u65f6\u8fd8\u6709\u4e00\u7cfb\u5217\u8de8\u8d8a\u4e0d\u540c\u4f5c\u7528\u673a\u5236\u7684\u6f5c\u5728\u65b0\u836f\u548c\u7ec4\u5408\u7684\u4ea7\u54c1\u7ba1\u7ebf\u3002<\/p>\n<p>\u963f\u65af\u5229\u5eb7\u662fLung Ambition Alliance\u7684\u521b\u59cb\u6210\u5458\uff0c\u8be5\u5168\u7403\u6027\u8054\u76df\u81f4\u529b\u4e8e\u52a0\u5feb\u521b\u65b0\u6b65\u4f10\uff0c\u5e76\u4e3a\u80ba\u764c\u60a3\u8005\u63d0\u4f9b\u5305\u62ec\u6cbb\u7597\u548c\u6cbb\u7597\u4ee5\u5916\u7684\u5177\u6709\u610f\u4e49\u7684\u6539\u5584\u63aa\u65bd\u3002<\/p>\n<p><b>\u5173\u4e8e\u963f\u65af\u5229\u5eb7\u80bf\u7624\u9886\u57df\u7684\u7814\u7a76<\/b><\/p>\n<p>\u963f\u65af\u5229\u5eb7\u6b63\u5f15\u9886\u7740\u80bf\u7624\u9886\u57df\u7684\u4e00\u573a\u9769\u547d\uff0c\u81f4\u529b\u63d0\u4f9b\u591a\u5143\u5316\u7684\u80bf\u7624\u6cbb\u7597\u65b9\u6848\uff0c\u4ee5\u79d1\u5b66\u63a2\u7d22\u80bf\u7624\u9886\u57df\u7684\u590d\u6742\u6027\uff0c\u53d1\u73b0\u3001\u7814\u53d1\u5e76\u5411\u60a3\u8005\u63d0\u4f9b\u6539\u53d8\u751f\u547d\u7684\u836f\u7269\u3002<\/p>\n<p>\u963f\u65af\u5229\u5eb7\u4e13\u6ce8\u4e8e\u6700\u5177\u6311\u6218\u6027\u7684\u80bf\u7624\u75be\u75c5\uff0c\u901a\u8fc7\u6301\u7eed\u4e0d\u65ad\u7684\u521b\u65b0\uff0c\u963f\u65af\u5229\u5eb7\u5df2\u7ecf\u5efa\u7acb\u4e86\u884c\u4e1a\u9886\u5148\u7684\u591a\u5143\u5316\u7684\u4ea7\u54c1\u7ec4\u5408\u548c\u7ba1\u7ebf\uff0c\u6301\u7eed\u63a8\u52a8\u533b\u7597\u5b9e\u8df5\u53d8\u9769\uff0c\u6539\u53d8\u60a3\u8005\u4f53\u9a8c\u3002<\/p>\n<p>\u963f\u65af\u5229\u5eb7\u4ee5\u671f\u91cd\u65b0\u5b9a\u4e49\u764c\u75c7\u6cbb\u7597\u5e76\u5728\u672a\u6765\u653b\u514b\u764c\u75c7\u3002<\/p>\n<p><b>\u5173\u4e8e\u963f\u65af\u5229\u5eb7<\/b><\/p>\n<p>\u963f\u65af\u5229\u5eb7\uff08LSE\/STO\/Nasdaq: AZN\uff09\u662f\u4e00\u5bb6\u79d1\u5b66\u81f3\u4e0a\u7684\u5168\u7403\u6027\u751f\u7269\u5236\u836f\u4f01\u4e1a\uff0c\u4e13\u6ce8\u4e8e\u7814\u53d1\u3001\u751f\u4ea7\u53ca\u8425\u9500\u5904\u65b9\u7c7b\u836f\u54c1\uff0c\u91cd\u70b9\u5173\u6ce8\u80bf\u7624\u548c\u5fc3\u8840\u7ba1\u3001\u80be\u810f\u53ca\u4ee3\u8c22\u3001\u547c\u5438\u53ca\u514d\u75ab\u4e09\u5927\u4e3b\u8981\u75be\u75c5\u7684\u751f\u7269\u5236\u836f\u3002\u963f\u65af\u5229\u5eb7\u5168\u7403\u603b\u90e8\u4f4d\u4e8e\u82f1\u56fd\u5251\u6865\uff0c\u4e1a\u52a1\u904d\u5e03\u4e16\u754c100\u591a\u4e2a\u56fd\u5bb6\uff0c\u521b\u65b0\u836f\u7269\u60e0\u53ca\u5168\u7403\u6570\u767e\u4e07\u60a3\u8005\u3002\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee<a href=\"http:\/\/www.astrazeneca.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.astrazeneca.com<\/a>\u3002<\/p>\n<p><b>\u5173\u4e8e\u548c\u9ec4\u533b\u836f<\/b><\/p>\n<p>\u548c\u9ec4\u533b\u836f\uff08\u7eb3\u65af\u8fbe\u514b\/\u4f26\u6566\u8bc1\u4ea4\u6240\uff1aHCM\uff1b\u9999\u6e2f\u4ea4\u6613\u6240\uff1a13\uff09\u662f\u4e00\u5bb6\u5904\u4e8e\u5546\u4e1a\u5316\u9636\u6bb5\u7684\u521b\u65b0\u578b\u751f\u7269\u533b\u836f\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u53d1\u73b0\u3001\u5168\u7403\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u6cbb\u7597\u764c\u75c7\u548c\u514d\u75ab\u6027\u75be\u75c5\u7684\u9776\u5411\u836f\u7269\u548c\u514d\u75ab\u7597\u6cd5\u3002\u96c6\u56e2\u65d7\u4e0b\u516c\u53f8\u5171\u6709\u7ea65,000\u540d\u5458\u5de5\uff0c\u5176\u4e2d\u6838\u5fc3\u7684\u80bf\u7624\/\u514d\u75ab\u4e1a\u52a1\u62e5\u6709\u7ea61,800\u4eba\u7684\u56e2\u961f\u3002\u81ea\u6210\u7acb\u4ee5\u6765\uff0c\u548c\u9ec4\u533b\u836f\u5728\u5168\u7403\u8303\u56f4\u5185\u81f4\u529b\u4e8e\u5c06\u81ea\u4e3b\u53d1\u73b0\u7684\u6297\u80bf\u7624\u5019\u9009\u836f\u7269\u60e0\u53ca\u60a3\u8005\uff0c\u5176\u4e2d\u9996\u4e09\u4e2a\u521b\u65b0\u80bf\u7624\u836f\u7269\u73b0\u5df2\u5728\u4e2d\u56fd\u83b7\u6279\u4e0a\u5e02\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u8be6\u60c5\uff0c\u8bf7\u8bbf\u95ee\uff1a<a href=\"https:\/\/www.hutch-med.com\/sc\" target=\"_blank\" rel=\"nofollow noopener\">www.hutch\u2013med.com<\/a>\u6216\u5173\u6ce8\u6211\u4eec\u7684<a href=\"https:\/\/www.linkedin.com\/company\/hutchmed\/\" target=\"_blank\" rel=\"nofollow noopener\">\u9886\u82f1<\/a>\u4e13\u9875\u3002<\/p>\n<p><b>\u53c2\u8003\u8d44\u6599<\/b><\/p>\n<p>1. World Health Organization. International Agency for Research on Cancer. All cancers fact sheet. Available at: <a href=\"https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/39-All-cancers-fact-sheet.pdf.\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/39-All-cancers-fact-sheet.pdf.<\/a> Accessed <span class=\"xn-chron\">November 2022<\/span>.<br \/>2. American Cancer Society. What is Lung Cancer? Available at: <a href=\"https:\/\/www.cancer.org\/cancer\/lung-cancer\/about\/what-is.html.\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.cancer.org\/cancer\/lung-cancer\/about\/what-is.html.<\/a> Accessed <span class=\"xn-chron\">November 2022<\/span>.<br \/>3. Knight SB, et al. Progress and prospects of early detection in lung cancer. Open Biol. 2017;7(9): 170070.<br \/>4. Keedy VL, et al. American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients with Advanced Non-Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy. J Clin Oncol. 2011:29;2121-27.<br \/>5. Zhang Y, et al. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget. 2016;7(48).<br \/>6. Szumera-Cie\u0107kiewicz A, et al.\u202fEGFR Mutation Testing on Cytological and Histological Samples in 11. Non-Small Cell Lung Cancer: a Polish, Single Institution. Study and Systematic Review of European Incidence.\u202fInt J Clin Exp Pathol. 2013:6;2800-12.\u202f<br \/>7. Uchikawa E, et al. Structural basis of the activation of c-MET receptor. <span class=\"xn-person\">Nat Commun<\/span>. 2021;12(4074).<br \/>8. Wang Q, et al. MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer. Journal of Hematology &amp; Oncology. 2019;63.<br \/>9. Vuong HG, et al. Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer \u2013 A systematic review and meta-analysis. Lung Cancer 2018; 123: 76-82. doi: 10.1016\/j.lungcan.2018.07.006.<br \/>10. Soria JC, et al. Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2018;378(2):113-125. doi:10.1056\/NEJMoa1713137.<br \/>11. Mok TS, et al. Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer. N Engl J Med. 2017;376(7):629-640. doi:10.1056\/NEJMoa1612674.<br \/>12. Hartmaier R, et al. Tumor genomics in patients (pts) with advanced epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC) whose disease has progressed on first-line (1L) osimertinib therapy in the Phase II ORCHARD study [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; Abstract nr LB078 \/ 3.<br \/>13. Piotrowska, et al.&nbsp; MET amplification (amp) as a resistance mechanism to osimertinib. Journal of Clinical Oncology 2017 35:15_suppl, 9020-9020&nbsp;<br \/>14. Hartmaier, et al. Detection of MET-mediated EGFR tyrosine kinase inhibitor (TKI) resistance in advanced non-small cell lung cancer (NSCLC): biomarker analysis of the TATTON study. Cancer Res (2019) 79 (13_Supplement): 4897.doi: 10.1158\/1538-7445.AM2019-4897.<br \/>15. Coleman N, et al. Beyond epidermal growth factor receptor: MET amplification as a general resistance driver to targeted therapy in oncogene-driven non-small-cell lung cancer. ESMO Open. 2019;6(6)<\/p>\n<p><i><b>\u524d\u77bb\u6027\u9648\u8ff0<\/b><\/i><\/p>\n<p><i>\u672c\u516c\u544a\u5305\u542b<\/i><i>1995\u5e74\u300a\u7f8e\u56fd\u79c1\u4eba<\/i><i>\u8bc1<\/i><i>\u5238<\/i><i>\u8bc9\u8bbc<\/i><i>\u6539\u9769\u6cd5\u6848\u300b&quot;\u5b89\u5168\u6e2f&quot;\u6761\u6b3e\u4e2d\u5b9a<\/i><i>\u4e49<\/i><i>\u7684\u524d\u77bb\u6027<\/i><i>\u9648<\/i><i>\u8ff0\u3002<\/i><i>\u8fd9<\/i><i>\u4e9b\u524d\u77bb\u6027<\/i><i>\u9648<\/i><i>\u8ff0\u53cd\u6620\u4e86\u548c\u9ec4\u533b<\/i><i>\u836f<\/i><i>\u76ee\u524d<\/i><i>\u5bf9<\/i><i>\u672a\u6765\u4e8b\u4ef6\u7684<\/i><i>\u9884<\/i><i>\u671f\uff0c\u5305\u62ec<\/i><i>\u5bf9\u8d5b<\/i><i>\u6c83\u66ff\u5c3c\u5728\u4e2d\u56fd\u5546<\/i><i>\u4e1a<\/i><i>\u5316\u7684<\/i><i>\u9884<\/i><i>\u671f\uff0c<\/i><i>\u5bf9\u8d5b<\/i><i>\u6c83\u66ff\u5c3c<\/i><i>\u6f5c\u5728\u6536\u76ca\u7684<\/i><i>\u9884<\/i><i>\u671f<\/i><i>\u4ee5\u53ca<\/i><i>\u4e34<\/i><i>\u5e8a\u5f00<\/i><i>\u53d1<\/i><i>\u7684<\/i><i>\u9884<\/i><i>\u671f\uff0c<\/i><i>\u5bf9\u8fdb<\/i><i>\u4e00\u6b65<\/i><i>\u7814\u7a76\u662f\u5426\u80fd\u8fbe\u5230\u5176\u4e3b\u8981\u6216\u6b21\u8981<\/i><i>\u7ec8<\/i><i>\u70b9\u7684<\/i><i>\u9884<\/i><i>\u671f\uff0c\u4ee5\u53ca<\/i><i>\u5bf9<\/i><i>\u6b64\u7c7b\u7814\u7a76\u5b8c\u6210<\/i><i>\u65f6\u95f4<\/i><i>\u548c<\/i><i>\u7ed3<\/i><i>\u679c<\/i><i>\u53d1<\/i><i>\u5e03\u7684<\/i><i>\u9884<\/i><i>\u671f\u3002<\/i><i>\u524d\u77bb\u6027<\/i><i>\u9648<\/i><i>\u8ff0\u6d89\u53ca<\/i><i>\u98ce\u9669<\/i><i>\u548c\u4e0d\u786e\u5b9a\u6027\u3002<\/i><i>\u6b64\u7c7b<\/i><i>\u98ce\u9669<\/i><i>\u548c\u4e0d\u786e\u5b9a\u6027\u5305\u62ec\u4e0b\u5217\u5047<\/i><i>\u8bbe<\/i><i>\uff1a<\/i><i>\u8d5b<\/i><i>\u6c83\u66ff\u5c3c\u5546<\/i><i>\u4e1a<\/i><i>\u63a5\u53d7\u5ea6<\/i><i>\uff0c\u8fdb\u5165\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\u5bf9\u5176\u9500\u552e\u53ca\u4ef7\u683c\u7684\u5f71\u54cd<\/i><i>\uff0c\u5165<\/i><i>\u7ec4<\/i><i>\u7387\uff0c<\/i><i>\u6ee1<\/i><i>\u8db3\u7814\u7a76\u5165<\/i><i>\u9009<\/i><i>\u548c\u6392\u9664<\/i><i>\u6807<\/i><i>\u51c6\u7684\u53d7<\/i><i>\u8bd5<\/i><i>\u8005\u7684<\/i><i>\u65f6\u95f4<\/i><i>\u548c\u53ef\u7528\u6027\uff0c<\/i><i>\u4e34<\/i><i>\u5e8a\u65b9\u6848\u6216<\/i><i>\u76d1<\/i><i>\u7ba1\u8981\u6c42<\/i><i>\u53d8<\/i><i>\u66f4\uff0c\u975e<\/i><i>\u9884<\/i><i>\u671f\u4e0d\u826f\u4e8b\u4ef6\u6216\u5b89\u5168\u6027<\/i><i>\u95ee\u9898<\/i><i>\uff0c\u5019<\/i><i>\u9009\u836f<\/i><i>\u7269<\/i><i>\u8d5b<\/i><i>\u6c83\u66ff\u5c3c\u7528\u4e8e\u76ee<\/i><i>\u6807<\/i><i>\u9002<\/i><i>\u5e94<\/i><i>\u75c7\u5728\u4e0d\u540c\u53f8\u6cd5\u7ba1<\/i><i>\u8f96<\/i><i>\u533a\u7684<\/i><i>\u83b7<\/i><i>\u5f97<\/i><i>\u76d1<\/i><i>\u7ba1\u6279\u51c6\u548c<\/i><i>\u8d44<\/i><i>\u91d1\u5145\u8db3\u6027\u7b49\u3002<\/i><i>\u6b64\u5916\uff0c\u7531\u4e8e\u90e8\u5206<\/i><i>\u4e34<\/i><i>\u5e8a<\/i><i>\u8bd5\u9a8c\u4e3a\u8054<\/i><i>\u5408<\/i><i>\u5965\u5e0c\u66ff\u5c3c\u53ca\u5ea6\u4f10\u5229\u5c24<\/i><i>\u5355<\/i><i>\u6297<\/i><i>\u4f7f\u7528\uff0c\u56e0\u6b64\u6b64\u7c7b<\/i><i>\u98ce\u9669<\/i><i>\u53ca<\/i><i>\u4e0d\u786e\u5b9a\u6027\u4ea6\u5305\u62ec\u6709\u5173\u5176\u5b89\u5168\u6027\u3001<\/i><i>\u7597<\/i><i>\u6548\u3001\u4f9b<\/i><i>\u5e94<\/i><i>\u53ca\u6301<\/i><i>\u7eed\u76d1<\/i><i>\u7ba1\u6279\u51c6\u7684\u5047<\/i><i>\u8bbe<\/i><i>\uff0c\u4ee5\u53ca\u65b0\u51a0\u80ba\u708e\u5168\u7403\u5927\u6d41\u884c<\/i><i>\u5bf9<\/i><i>\u6574\u4f53<\/i><i>\u7ecf\u6d4e<\/i><i>\u3001<\/i><i>\u76d1<\/i><i>\u7ba1\u53ca\u653f\u6cbb\u72b6\u51b5<\/i><i>\u5e26<\/i><i>\u6765\u7684\u5f71\u54cd\u7b49\u3002<\/i><i>\u5f53\u524d\u548c\u6f5c\u5728\u6295<\/i><i>\u8d44<\/i><i>\u8005<\/i><i>\u8bf7<\/i><i>\u52ff<\/i><i>\u8fc7<\/i><i>\u5ea6\u4f9d<\/i><i>\u8d56\u8fd9<\/i><i>\u4e9b\u524d\u77bb\u6027<\/i><i>\u9648<\/i><i>\u8ff0\uff0c<\/i><i>\u8fd9<\/i><i>\u4e9b<\/i><i>\u9648<\/i><i>\u8ff0<\/i><i>\u4ec5<\/i><i>\u5728\u622a\u81f3\u672c<\/i><i>\u516c\u544a<\/i><i>\u53d1<\/i><i>\u5e03\u5f53\u65e5\u6709\u6548\u3002<\/i><i>\u6709\u5173<\/i><i>\u8fd9<\/i><i>\u4e9b<\/i><i>\u98ce\u9669<\/i><i>\u548c\u5176\u4ed6<\/i><i>\u98ce\u9669<\/i><i>\u7684<\/i><i>\u8fdb<\/i><i>\u4e00\u6b65<\/i><i>\u8ba8\u8bba<\/i><i>\uff0c<\/i><i>\u8bf7\u67e5\u9605<\/i><i>\u548c\u9ec4\u533b<\/i><i>\u836f<\/i><i>\u5411\u7f8e\u56fd<\/i><i>\u8bc1<\/i><i>\u5238\u4ea4\u6613\u59d4<\/i><i>\u5458<\/i><i>\u4f1a\u3001<\/i><i>AIM\u548c\u9999\u6e2f<\/i><i>\u8054<\/i><i>\u5408\u4ea4\u6613\u6240\u6709\u9650\u516c\u53f8\u63d0\u4ea4\u7684\u6587\u4ef6\u3002<\/i><i>\u65e0<\/i><i>\u8bba<\/i><i>\u662f\u5426\u51fa<\/i><i>\u73b0<\/i><i>\u65b0<\/i><i>\u8d44\u8baf<\/i><i>\u3001\u672a\u6765\u4e8b\u4ef6\u6216\u60c5\u51b5\u6216\u5176\u4ed6\u56e0\u7d20\uff0c\u548c\u9ec4\u533b<\/i><i>\u836f<\/i><i>\u5747\u4e0d\u627f\u62c5\u66f4\u65b0\u6216\u4fee<\/i><i>\u8ba2<\/i><i>\u672c<\/i><i>\u516c\u544a\u6240\u542b<\/i><i>\u8d44\u8baf<\/i><i>\u7684<\/i><i>\u4e49\u52a1<\/i><i>\u3002<\/i><\/p>\n<p><i><b>\u5185\u5e55\u6d88\u606f<\/b><\/i><\/p>\n<p><i>\u672c\u516c\u544a\u5305\u542b\uff08\u6b27\u76df\uff09\u7b2c<\/i><i>596\/2014\u53f7\u6761\u4f8b\uff08<\/i><i>\u8be5<\/i><i>\u6761\u4f8b\u6784\u6210\u300a<\/i><i>2018\u5e74\u6b27\u6d32<\/i><i>\u8054<\/i><i>\u76df\uff08\u9000\u51fa\uff09\u6cd5\u300b\u5b9a<\/i><i>\u4e49<\/i><i>\u7684\u6b27\u76df\u4fdd\u7559\u6cd5\u5f8b\u7684\u4e00\u90e8\u5206\uff09\u7b2c<\/i><i>7\u6761<\/i><i>\u89c4<\/i><i>\u5b9a\u7684\u5185\u5e55\u6d88\u606f\u3002<\/i><\/p>\n<p><b>\u963f\u65af\u5229\u5eb7\u8054\u7edc\u65b9\u6cd5<\/b><\/p>\n<p>\u6295\u8d44\u8005\u54a8\u8be2\uff1a &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<a href=\"https:\/\/www.astrazeneca.com\/investor-relations.html\" target=\"_blank\" rel=\"nofollow noopener\">\u70b9\u51fb\u6b64\u5904\u4e86\u89e3\u8be6\u60c5<\/a><\/p>\n<p>\u5a92\u4f53\u54a8\u8be2\uff1a&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <a href=\"https:\/\/www.astrazeneca.com\/media-centre\/contacts.html\" target=\"_blank\" rel=\"nofollow noopener\">\u70b9\u51fb\u6b64\u5904\u4e86\u89e3\u8be6\u60c5<\/a><\/p>\n<p>&nbsp;<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\">  <\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u9999\u6e2f\u3001\u4e0a\u6d77\u548c\u65b0\u6cfd\u897f\u5dde2023\u5e741\u670819\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u548c\u9ec4\u533b\u836f\uff08\u4e2d\u56fd\uff09\u6709\u9650\u516c\u53f8\uff08\u7b80\u79f0&quot;\u548c\u9ec4\u533b\u836f&quot;\u6216&quot;HUTCHMED&quot;\uff09\uff08\u7eb3\u65af\u8fbe\u514b\/\u4f26\u6566\u8bc1\u4ea4\u6240\uff1aHCM\uff1b\u9999\u6e2f\u4ea4\u6613\u6240\uff1a13\uff09\u4eca\u5929\u5ba3\u5e03\uff0c\u7ecf\u8fc7\u4e0e\u4e2d\u56fd\u56fd\u5bb6\u533b\u7597\u4fdd\u969c\u5c40\uff08&quot;\u56fd\u5bb6\u533b\u4fdd\u5c40&quot;\uff09\u7684\u533b\u4fdd\u8c08\u5224\uff0c\u6c83\u745e\u6c99&reg;\uff08\u8d5b\u6c83\u66ff\u5c3c\uff09\u83b7\u7eb3\u5165\u65b0\u7248\u300a\u56fd\u5bb6\u57fa\u672c\u533b\u7597\u4fdd\u9669\u3001\u5de5\u4f24\u4fdd\u9669\u548c\u751f\u80b2\u4fdd\u9669\u836f\u54c1\u76ee\u5f55\u300b\uff08&quot;\u533b\u4fdd\u836f\u54c1\u76ee\u5f55&quot;\uff09\uff0c\u7528\u4e8e\u6cbb\u7597\u542b\u94c2\u5316\u7597\u540e\u75be\u75c5\u8fdb\u5c55\u6216\u4e0d\u8010\u53d7\u6807\u51c6\u542b\u94c2\u5316\u7597\u7684\u95f4\u5145\u8d28\u4e0a\u76ae\u8f6c\u5316\u56e0\u5b50\uff08&quot;MET&quot;\uff09 \u5916\u663e\u5b50&nbsp;14 \u8df3\u53d8\u7684\u5c40\u90e8\u665a\u671f\u6216\u8f6c\u79fb\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u6210\u4eba\u60a3\u8005\u3002\u65b0\u7248\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\u5c06\u81ea2023\u5e743\u67081\u65e5\u8d77\u751f\u6548\u3002 \u8d5b\u6c83\u66ff\u5c3c\u5728\u4e2d\u56fd\u4ee5\u5546\u54c1\u540d\u6c83\u745e\u6c99&reg;\u4e0a\u5e02\uff0c\u662f\u4e00\u79cd\u5f3a\u6548\u3001\u9ad8\u9009\u62e9\u6027\u7684\u53e3\u670dMET\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff08&quot;TKI&quot;\uff09\uff0c\u7531\u963f\u65af\u5229\u5eb7\u4e0e\u548c\u9ec4\u533b\u836f\u8054\u5408\u5f00\u53d1\uff0c\u5176\u4e2d\u5728\u4e2d\u56fd\u7684\u8054\u5408\u5f00\u53d1\u7531\u548c\u9ec4\u533b\u836f\u4e3b\u5bfc\uff0c\u5e76\u7531\u963f\u65af\u5229\u5eb7\u8d1f\u8d23\u5728\u5168\u7403\u8303\u56f4\u5185\u7684\u5546\u4e1a\u5316\u3002 \u548c\u9ec4\u533b\u836f\u9996\u5e2d\u6267\u884c\u5b98\u517c\u9996\u5e2d\u79d1\u5b66\u5b98\u82cf\u6170\u56fd\u535a\u58eb\u8868\u793a\uff1a&quot;\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\u80fd\u591f\u5e2e\u52a9\u66f4\u5e7f\u6cdb\u7684\u4e2d\u56fd\u60a3\u8005\u7528\u4e0a\u521b\u65b0\u836f\u3002\u5f88\u9ad8\u5174\u770b\u5230\u6211\u4eec\u7b2c\u4e09\u6b3e\u521b\u65b0\u6297\u80bf\u7624\u836f\u7269\u6c83\u745e\u6c99&reg;\u83b7\u7eb3\u5165\u4eca\u5e74\u7684\u65b0\u7248\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\u3002 \u4f5c\u4e3a\u4e2d\u56fd\u5e02\u573a\u4e0a\u9996\u4e2a\u4ea6\u662f\u76ee\u524d\u552f\u4e00\u83b7\u6279\u4e0a\u5e02\u7684\u9009\u62e9\u6027MET\u6291\u5236\u5242\uff0c\u6c83\u745e\u6c99&reg;\u83b7\u7eb3\u5165\u533b\u4fdd\uff0c\u5c06\u5927\u5927\u63d0\u9ad8\u8be5\u521b\u65b0\u7597\u6cd5\u7684\u53ef\u8d1f\u62c5\u6027\u548c\u53ef\u53ca\u6027\u3002&quot; \u963f\u65af\u5229\u5eb7\u5168\u7403\u6267\u884c\u526f\u603b\u88c1\u3001\u56fd\u9645\u4e1a\u52a1\u53ca\u4e2d\u56fd\u603b\u88c1\u738b\u78ca\u5148\u751f\u8868\u793a\uff1a&quot;\u6b64\u6b21\u6c83\u745e\u6c99&reg;\u83b7\u7eb3\u5165\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\uff0c\u5bf9\u4e8e\u6570\u4ee5\u5343\u8ba1\u7684MET\u5916\u663e\u5b5014\u8df3\u8dc3\u7a81\u53d8\u7684\u4e2d\u56fd\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u6765\u8bf4\uff0c\u662f\u4e00\u4e2a\u4ee4\u4eba\u632f\u594b\u7684\u6d88\u606f\u3002\u8fd9\u4e9b\u60a3\u8005\u5f80\u5f80\u5bf9\u5316\u7597\u53cd\u5e94\u4e0d\u4f73\uff0c\u73b0\u5728\u4ed6\u4eec\u80fd\u591f\u66f4\u5bb9\u6613\u5730\u83b7\u53d6\u8be5\u9002\u5e94\u75c7\u552f\u4e00\u83b7\u6279\u7684\u9776\u5411\u836f\u7269\u3002\u6c83\u745e\u6c99&reg;\u81ea2021\u5e74\u5e74\u4e2d\u4e0a\u5e02\u4ee5\u6765\uff0c\u5df2\u5e2e\u52a9\u6709\u9700\u8981\u7684\u60a3\u8005\u83b7\u5f97\u66f4\u597d\u7684\u6cbb\u7597\u6548\u679c\uff0c\u6211\u4eec\u5f88\u671f\u5f85\u66f4\u591a\u4e2d\u56fd\u60a3\u8005\u5c06\u6709\u671b\u83b7\u76ca\u4e8e\u8be5\u9769\u547d\u6027\u7684\u836f\u7269\u3002&quot; \u6c83\u745e\u6c99&reg;\u4e8e2021\u5e746\u6708\u5728\u4e2d\u56fd\u83b7\u9644\u6761\u4ef6\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u7279\u5b9a\u7684MET\u5916\u663e\u5b5014\u8df3\u8dc3\u7a81\u53d8\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u3002 \u5173\u4e8e\u533b\u4fdd\u836f\u54c1\u76ee\u5f55 \u8fd1\u5e74\u6765\uff0c\u4e2d\u56fd\u653f\u5e9c\u9ad8\u5ea6\u91cd\u89c6\u51cf\u8f7b\u4eba\u6c11\u7fa4\u4f17\u7528\u836f\u8d1f\u62c5\u95ee\u9898\u3002\u56fd\u5bb6\u533b\u4fdd\u5c40\u76ee\u524d\u5b9a\u671f\u53ec\u96c6\u4e00\u4e2a\u5e7f\u6cdb\u7684\u4e13\u5bb6\u7f51\u7edc\uff0c\u5305\u62ec\u533b\u5b66\u4e13\u5bb6\u3001\u836f\u5b66\u4e13\u5bb6\u548c\u836f\u7269\u7ecf\u6d4e\u5b66\u4e13\u5bb6\u7b49\uff0c\u5bf9\u521b\u65b0\u836f\u7269\u51c6\u5165\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\u8fdb\u884c\u66f4\u65b0\u548c\u8c03\u6574\u3002\u56e0\u6b64\u4e59\u7c7b\u836f\u7269\u7684\u62a5\u9500\u8303\u56f4\u8fc5\u901f\u6269\u5927\uff0c\u5176\u4e2d\u8d8a\u6765\u8d8a\u591a\u5730\u5305\u62ec\u65b0\u578b\u6297\u80bf\u7624\u836f\u7269\u3002\u4e59\u7c7b\u836f\u7269\u7684\u62a5\u9500\u8981\u6c42\u60a3\u8005\u6839\u636e\u5176\u5c45\u4f4f\u7701\u4efd\u6216\u53c2\u52a0\u7684\u533b\u7597\u4fdd\u9669\u7c7b\u578b\uff0c\u652f\u4ed8\u4e0d\u540c\u6bd4\u4f8b\u7684\u81ea\u4ed8\u989d\u3002\u6240\u6709\u5305\u62ec\u7684\u836f\u7269\u7684\u534f\u8bae\u901a\u5e38\u6bcf\u4e24\u5e74\u66f4\u65b0\u4e00\u6b21\u3002 \u5728\u8fd9\u6b21\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\u8c03\u6574\u4e2d\uff0c\u56fd\u5bb6\u533b\u4fdd\u5c40\u5171\u65b0\u589e23\u4e2a\u6297\u80bf\u7624\u836f\u7269\uff0c\u5176\u4e2d\u5305\u62ec\u6c83\u745e\u6c99&reg;\u3002\u81ea2023\u5e743\u67081\u65e5\u8d77\uff0c\u5c06\u5728\u5168\u56fd\u5404\u5927\u533b\u9662\u836f\u623f\u6309\u7167\u533b\u4fdd\u652f\u4ed8\u6807\u51c6\u6267\u884c\u8c08\u5224\u4ef7\u683c\uff0c\u5e76\u5bf9\u53c2\u4fdd\u4eba\u5458\u6309\u7167\u4e00\u5b9a\u6bd4\u4f8b\u7ed9\u4ed8\u3002 \u5173\u4e8e\u8d5b\u6c83\u66ff\u5c3c \u8d5b\u6c83\u66ff\u5c3c\u662f\u4e00\u79cd\u5f3a\u6548\u3001\u9ad8\u9009\u62e9\u6027\u7684\u53e3\u670dMET TKI\uff0c\u5728\u665a\u671f\u5b9e\u4f53\u7624\u4e2d\u8868\u73b0\u51fa\u4e34\u5e8a\u6d3b\u6027\u3002\u8d5b\u6c83\u66ff\u5c3c\u53ef\u963b\u65ad\u56e0\u7a81\u53d8\uff08\u4f8b\u5982\u5916\u663e\u5b5014\u8df3\u8dc3\u7a81\u53d8\u6216\u5176\u4ed6\u70b9\u7a81\u53d8\uff09\u3001\u57fa\u56e0\u6269\u589e\u6216\u86cb\u767d\u8d28\u8fc7\u8868\u8fbe\u800c\u5bfc\u81f4\u7684MET\u53d7\u4f53\u916a\u6c28\u9178\u6fc0\u9176\u4fe1\u53f7\u901a\u8def\u7684\u5f02\u5e38\u6fc0\u6d3b\u3002 \u8d5b\u6c83\u66ff\u5c3c\u5728\u4e2d\u56fd\u4ee5\u5546\u54c1\u540d\u6c83\u745e\u6c99&reg;\u4e0a\u5e02\uff0c\u7528\u4e8e\u6cbb\u7597\u63a5\u53d7\u5168\u8eab\u6027\u6cbb\u7597\u540e\u75be\u75c5\u8fdb\u5c55\u6216\u65e0\u6cd5\u63a5\u53d7\u5316\u7597\u7684MET\u5916\u663e\u5b5014\u8df3\u8dc3\u7a81\u53d8\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u3002\u76ee\u524d\uff0c\u8d5b\u6c83\u66ff\u5c3c\u6b63\u4f5c\u4e3a\u5355\u836f\u7597\u6cd5\u6216\u4e0e\u5176\u4ed6\u836f\u7269\u7684\u8054\u5408\u7597\u6cd5\uff0c\u5f00\u53d1\u7528\u4e8e\u6cbb\u7597\u5305\u62ec\u80ba\u764c\u3001\u80be\u764c\u548c\u80c3\u764c\u5728\u5185\u7684\u591a\u79cd\u80bf\u7624\u7c7b\u578b\u3002 \u5173\u4e8e\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u53caMET\u5f02\u5e38 \u80ba\u764c\u662f\u7537\u6027\u548c\u5973\u6027\u764c\u75c7\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\uff0c\u7ea6\u5360\u6240\u6709\u764c\u75c7\u6b7b\u4ea1\u4eba\u6570\u7684\u4e94\u5206\u4e4b\u4e00\u30021&nbsp;\u80ba\u764c\u901a\u5e38\u5206\u4e3a\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u548c\u5c0f\u7ec6\u80de\u80ba\u764c\uff08SCLC\uff09\uff0c\u5176\u4e2d80-85%\u4e3a\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u30022&nbsp;\u5927\u90e8\u5206\uff08\u7ea675%\uff09\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u5728\u786e\u8bca\u65f6\u5df2\u662f\u665a\u671f\uff0c\u800c\u7f8e\u56fd\u548c\u6b27\u6d32\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u4e2d\u7ea6\u670910-25\uff05\u5b58\u5728EGFR\u7a81\u53d8\uff0c\u800c\u4e9a\u6d32\u60a3\u8005\u4e2d\u8be5\u6bd4\u4f8b\u9ad8\u8fbe30-40\uff05\u30023, 4,&nbsp; 5, 6 MET\u662f\u4e00\u79cd\u53d7\u4f53\u916a\u6c28\u9178\u6fc0\u9176\uff0c\u5728\u7ec6\u80de\u7684\u6b63\u5e38\u53d1\u80b2\u8fc7\u7a0b\u4e2d\u53d1\u6325\u91cd\u8981\u4f5c\u7528\u30027&nbsp;MET\u6269\u589e\u6216\u8fc7\u8868\u8fbe\u53ef\u5bfc\u81f4\u80bf\u7624\u751f\u957f\u4ee5\u53ca\u764c\u7ec6\u80de\u7684\u8f6c\u79fb\u8fdb\u5c55\uff0c\u4e14\u662fEGFR\u7a81\u53d8\u7684\u8f6c\u79fb\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u5bf9EGFR TKI\u6cbb\u7597\u4ea7\u751f\u83b7\u5f97\u6027\u8010\u836f\u7684\u4e3b\u8981\u673a\u5236\u4e4b\u4e00\u30027,&nbsp;8&nbsp;&nbsp;\u7ea6\u67092%-3%\u7684\u60a3\u8005\u4f34\u6709MET\u5916\u663e\u5b5014\u8df3\u8dc3\u7a81\u53d8\uff0c\u8fd9\u662f\u4e00\u79cd\u7279\u5b9a\u7684\u57fa\u56e0\u7a81\u53d8\u30029 \u5728\u5965\u5e0c\u66ff\u5c3c\u6cbb\u7597\u540e\u51fa\u73b0\u75be\u75c5\u8fdb\u5c55\u7684\u60a3\u8005\u4e2d\uff0cMET\u5f02\u5e38\u7684\u53d1\u751f\u7387\u4e3a15-50%\u300210,11,12,13,14&nbsp; MET\u6269\u589e\u548c\u8fc7\u8868\u8fbe\u7684\u53d1\u751f\u7387\u53ef\u80fd\u56e0\u6837\u54c1\u7c7b\u578b\u3001\u68c0\u6d4b\u65b9\u6cd5\u548c\u4f7f\u7528\u7684\u6d4b\u5b9a\u9608\u503c\u800c\u5f02\u300215 \u5173\u4e8e\u963f\u65af\u5229\u5eb7\u4e0e\u548c\u9ec4\u533b\u836f\u7684\u5408\u4f5c \u548c\u9ec4\u533b\u836f\u4e0e\u963f\u65af\u5229\u5eb7\u4e8e2011\u5e74\u8fbe\u6210\u4e00\u9879\u5168\u7403\u8bb8\u53ef\u548c\u5408\u4f5c\u534f\u8bae\uff0c\u65e8\u5728\u5171\u540c\u5f00\u53d1\u8d5b\u6c83\u66ff\u5c3c\u5e76\u4fc3\u8fdb\u5176\u5546\u4e1a\u5316\u3002\u8d5b\u6c83\u66ff\u5c3c\u5728\u4e2d\u56fd\u7684\u8054\u5408\u5f00\u53d1\u7531\u548c\u9ec4\u533b\u836f\u4e3b\u5bfc\uff0c\u5e76\u7531\u963f\u65af\u5229\u5eb7\u4e3b\u5bfc\u5176\u6d77\u5916\u5f00\u53d1\u3002\u548c\u9ec4\u533b\u836f\u8d1f\u8d23\u8d5b\u6c83\u66ff\u5c3c\u5728\u4e2d\u56fd\u7684\u4e0a\u5e02\u8bb8\u53ef\u3001\u751f\u4ea7\u548c\u4f9b\u5e94\uff0c\u800c\u963f\u65af\u5229\u5eb7\u5219\u8d1f\u8d23\u8d5b\u6c83\u66ff\u5c3c\u5728\u4e2d\u56fd\u4e43\u81f3\u5168\u7403\u8303\u56f4\u5185\u7684\u5546\u4e1a\u5316\u3002\u8d5b\u6c83\u66ff\u5c3c\u7684\u9500\u552e\u6536\u5165\u7531\u963f\u65af\u5229\u5eb7\u786e\u8ba4\u3002 \u5173\u4e8e\u963f\u65af\u5229\u5eb7\u5728\u80ba\u764c\u9886\u57df\u7684\u7814\u7a76 \u963f\u65af\u5229\u5eb7\u6b63\u81f4\u529b\u4e8e\u901a\u8fc7\u65e9\u8bca\u65e9\u6cbb\u63d0\u9ad8\u80ba\u764c\u60a3\u8005\u7684\u6cbb\u6108\u7387\uff0c\u540c\u65f6\u63a8\u52a8\u76f8\u5173\u6280\u672f\u4e0d\u65ad\u5411\u524d\u53d1\u5c55\uff0c\u4ee5\u6539\u5584\u4ea7\u751f\u8010\u836f\u6027\u548c\u5904\u4e8e\u665a\u671f\u60c5\u51b5\u4e0b\u7684\u60a3\u8005\u7684\u6cbb\u7597\u7ed3\u679c\u3002\u901a\u8fc7\u5236\u5b9a\u65b0\u7684\u6cbb\u7597\u76ee\u6807\u548c\u7814\u7a76\u521b\u65b0\u7597\u6cd5\uff0c\u963f\u65af\u5229\u5eb7\u81f4\u529b\u4e8e\u5b9e\u73b0\u7528\u836f\u60a3\u8005\u53d7\u76ca\u6700\u5927\u5316\u7684\u76ee\u6807\u3002 \u516c\u53f8\u4e30\u5bcc\u7684\u4ea7\u54c1\u7ec4\u5408\u5305\u62ec\u9886\u5148\u7684\u80ba\u764c\u836f\u7269\u4ee5\u53ca\u4e0b\u4e00\u9636\u6bb5\u7684\u521b\u65b0\u836f\u7269\uff0c\u5305\u62ec\u6cf0\u745e\u6c99&reg;\uff08\u5965\u5e0c\u66ff\u5c3c\uff09\u3001\u6613\u745e\u6c99&reg;\uff08\u5409\u975e\u66ff\u5c3c\u7247\uff09\u3001\u82f1\u98de\u51e1&reg;\uff08&nbsp;\u5ea6\u4f10\u5229\u5c24\u5355\u6297\uff09\u548cIMJUDO&reg;\uff08\u66f2\u7f8e\u6728\u5355\u6297\uff09\uff1b\u4e0e\u7b2c\u4e00\u4e09\u5171\uff08Daiichi Sankyo\uff09\u5408\u4f5c\u7814\u53d1\u7684ENHERTU&reg; (trastuzumab deruxtecan) \u548cdatopotamab deruxtecan\uff1b\u4e0e\u548c\u9ec4\u533b\u836f\u5408\u4f5c\u7814\u53d1\u7684\u6c83\u745e\u6c99&reg;\uff08\u8d5b\u6c83\u66ff\u5c3c\uff09\uff1b\u540c\u65f6\u8fd8\u6709\u4e00\u7cfb\u5217\u8de8\u8d8a\u4e0d\u540c\u4f5c\u7528\u673a\u5236\u7684\u6f5c\u5728\u65b0\u836f\u548c\u7ec4\u5408\u7684\u4ea7\u54c1\u7ba1\u7ebf\u3002 \u963f\u65af\u5229\u5eb7\u662fLung Ambition Alliance\u7684\u521b\u59cb\u6210\u5458\uff0c\u8be5\u5168\u7403\u6027\u8054\u76df\u81f4\u529b\u4e8e\u52a0\u5feb\u521b\u65b0\u6b65\u4f10\uff0c\u5e76\u4e3a\u80ba\u764c\u60a3\u8005\u63d0\u4f9b\u5305\u62ec\u6cbb\u7597\u548c\u6cbb\u7597\u4ee5\u5916\u7684\u5177\u6709\u610f\u4e49\u7684\u6539\u5584\u63aa\u65bd\u3002 \u5173\u4e8e\u963f\u65af\u5229\u5eb7\u80bf\u7624\u9886\u57df\u7684\u7814\u7a76 \u963f\u65af\u5229\u5eb7\u6b63\u5f15\u9886\u7740\u80bf\u7624\u9886\u57df\u7684\u4e00\u573a\u9769\u547d\uff0c\u81f4\u529b\u63d0\u4f9b\u591a\u5143\u5316\u7684\u80bf\u7624\u6cbb\u7597\u65b9\u6848\uff0c\u4ee5\u79d1\u5b66\u63a2\u7d22\u80bf\u7624\u9886\u57df\u7684\u590d\u6742\u6027\uff0c\u53d1\u73b0\u3001\u7814\u53d1\u5e76\u5411\u60a3\u8005\u63d0\u4f9b\u6539\u53d8\u751f\u547d\u7684\u836f\u7269\u3002 \u963f\u65af\u5229\u5eb7\u4e13\u6ce8\u4e8e\u6700\u5177\u6311\u6218\u6027\u7684\u80bf\u7624\u75be\u75c5\uff0c\u901a\u8fc7\u6301\u7eed\u4e0d\u65ad\u7684\u521b\u65b0\uff0c\u963f\u65af\u5229\u5eb7\u5df2\u7ecf\u5efa\u7acb\u4e86\u884c\u4e1a\u9886\u5148\u7684\u591a\u5143\u5316\u7684\u4ea7\u54c1\u7ec4\u5408\u548c\u7ba1\u7ebf\uff0c\u6301\u7eed\u63a8\u52a8\u533b\u7597\u5b9e\u8df5\u53d8\u9769\uff0c\u6539\u53d8\u60a3\u8005\u4f53\u9a8c\u3002 \u963f\u65af\u5229\u5eb7\u4ee5\u671f\u91cd\u65b0\u5b9a\u4e49\u764c\u75c7\u6cbb\u7597\u5e76\u5728\u672a\u6765\u653b\u514b\u764c\u75c7\u3002 \u5173\u4e8e\u963f\u65af\u5229\u5eb7 \u963f\u65af\u5229\u5eb7\uff08LSE\/STO\/Nasdaq: AZN\uff09\u662f\u4e00\u5bb6\u79d1\u5b66\u81f3\u4e0a\u7684\u5168\u7403\u6027\u751f\u7269\u5236\u836f\u4f01\u4e1a\uff0c\u4e13\u6ce8\u4e8e\u7814\u53d1\u3001\u751f\u4ea7\u53ca\u8425\u9500\u5904\u65b9\u7c7b\u836f\u54c1\uff0c\u91cd\u70b9\u5173\u6ce8\u80bf\u7624\u548c\u5fc3\u8840\u7ba1\u3001\u80be\u810f\u53ca\u4ee3\u8c22\u3001\u547c\u5438\u53ca\u514d\u75ab\u4e09\u5927\u4e3b\u8981\u75be\u75c5\u7684\u751f\u7269\u5236\u836f\u3002\u963f\u65af\u5229\u5eb7\u5168\u7403\u603b\u90e8\u4f4d\u4e8e\u82f1\u56fd\u5251\u6865\uff0c\u4e1a\u52a1\u904d\u5e03\u4e16\u754c100\u591a\u4e2a\u56fd\u5bb6\uff0c\u521b\u65b0\u836f\u7269\u60e0\u53ca\u5168\u7403\u6570\u767e\u4e07\u60a3\u8005\u3002\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95eewww.astrazeneca.com\u3002 \u5173\u4e8e\u548c\u9ec4\u533b\u836f \u548c\u9ec4\u533b\u836f\uff08\u7eb3\u65af\u8fbe\u514b\/\u4f26\u6566\u8bc1\u4ea4\u6240\uff1aHCM\uff1b\u9999\u6e2f\u4ea4\u6613\u6240\uff1a13\uff09\u662f\u4e00\u5bb6\u5904\u4e8e\u5546\u4e1a\u5316\u9636\u6bb5\u7684\u521b\u65b0\u578b\u751f\u7269\u533b\u836f\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u53d1\u73b0\u3001\u5168\u7403\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u6cbb\u7597\u764c\u75c7\u548c\u514d\u75ab\u6027\u75be\u75c5\u7684\u9776\u5411\u836f\u7269\u548c\u514d\u75ab\u7597\u6cd5\u3002\u96c6\u56e2\u65d7\u4e0b\u516c\u53f8\u5171\u6709\u7ea65,000\u540d\u5458\u5de5\uff0c\u5176\u4e2d\u6838\u5fc3\u7684\u80bf\u7624\/\u514d\u75ab\u4e1a\u52a1\u62e5\u6709\u7ea61,800\u4eba\u7684\u56e2\u961f\u3002\u81ea\u6210\u7acb\u4ee5\u6765\uff0c\u548c\u9ec4\u533b\u836f\u5728\u5168\u7403\u8303\u56f4\u5185\u81f4\u529b\u4e8e\u5c06\u81ea\u4e3b\u53d1\u73b0\u7684\u6297\u80bf\u7624\u5019\u9009\u836f\u7269\u60e0\u53ca\u60a3\u8005\uff0c\u5176\u4e2d\u9996\u4e09\u4e2a\u521b\u65b0\u80bf\u7624\u836f\u7269\u73b0\u5df2\u5728\u4e2d\u56fd\u83b7\u6279\u4e0a\u5e02\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u8be6\u60c5\uff0c\u8bf7\u8bbf\u95ee\uff1awww.hutch\u2013med.com\u6216\u5173\u6ce8\u6211\u4eec\u7684\u9886\u82f1\u4e13\u9875\u3002 \u53c2\u8003\u8d44\u6599 1. World Health Organization. International&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/2023011900080088814\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":88817,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-88814","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/88814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=88814"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/88814\/revisions"}],"predecessor-version":[{"id":88816,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/88814\/revisions\/88816"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/88817"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=88814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=88814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=88814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}